Richardson A, Shannon J D, Adams R B, Schaller M D, Parsons J
Department of Microbiology, University of Virginia, Charlottesville, VA 22908, USA.
Biochem J. 1997 May 15;324 ( Pt 1)(Pt 1):141-9. doi: 10.1042/bj3240141.
Focal adhesion kinase (pp125(FAK)) is a protein tyrosine kinase that is localized to focal adhesions in many cell types and which undergoes tyrosine phosphorylation after integrin binding to extracellular matrix. In some cells the C-terminal non-catalytic domain of pp125(FAK) is expressed as a separate protein referred to as FRNK (FAK-related, non-kinase). We have previously shown that overexpression of FRNK inhibits tyrosine phosphorylation of pp125(FAK) and its substrates as well as inhibiting cell spreading on fibronectin. In this report we identify Ser148 and Ser151 as residues in FRNK that are phosphorylated after tyrosine phosphorylation of pp125(FAK) and in response to integrin binding to fibronectin. Tyrosine phosphorylation of pp125(FAK) appears to be an early event after integrin occupancy, and serine phosphorylation of FRNK occurs significantly later. Treatment of fibroblasts with a series of protein kinase A inhibitors delayed serine phosphorylation of FRNK as well as cell spreading on fibronectin and tyrosine phosphorylation of pp125(FAK). However, these PKA inhibitors are unlikely to delay cell spreading simply by preventing serine phosphorylation of FRNK, as overexpression of FRNK containing mutations of Ser148 and Ser151 either singly or jointly to either alanine or glutamate residues did not significantly alter the ability of FRNK to act as an inhibitor of pp125(FAK).
粘着斑激酶(pp125(FAK))是一种蛋白酪氨酸激酶,在许多细胞类型中定位于粘着斑,在整合素与细胞外基质结合后会发生酪氨酸磷酸化。在某些细胞中,pp125(FAK)的C末端非催化结构域作为一种单独的蛋白质表达,称为FRNK(FAK相关非激酶)。我们之前已经表明,FRNK的过表达会抑制pp125(FAK)及其底物的酪氨酸磷酸化,以及抑制细胞在纤连蛋白上的铺展。在本报告中,我们确定Ser148和Ser151是FRNK中的残基,在pp125(FAK)发生酪氨酸磷酸化后以及响应整合素与纤连蛋白结合时会被磷酸化。pp125(FAK)的酪氨酸磷酸化似乎是整合素占据后的早期事件,而FRNK的丝氨酸磷酸化则明显较晚发生。用一系列蛋白激酶A抑制剂处理成纤维细胞会延迟FRNK的丝氨酸磷酸化以及细胞在纤连蛋白上的铺展和pp125(FAK)的酪氨酸磷酸化。然而,这些蛋白激酶A抑制剂不太可能仅仅通过阻止FRNK的丝氨酸磷酸化来延迟细胞铺展,因为单独或联合将Ser148和Ser151突变为丙氨酸或谷氨酸残基的FRNK过表达并没有显著改变FRNK作为pp125(FAK)抑制剂的作用能力。